Literature DB >> 20204605

To investigate the role of the nervous system of bone in steroid-induced osteonecrosis in rabbits.

L Wang1, N Wang, M Li, K Wang.   

Abstract

SUMMARY: Glucocorticoid treatment frequently causes osteonecrosis of the femoral head. The precise mechanism in the pathogenesis of osteonecrosis remains highly controversial. Normal bone metabolism requires a coordinated interaction between the sensory/sympathetic nervous system and cells within the bone tissue. So we speculated that neural lesions may be involved in osteonecrosis.
OBJECTIVE: using a rabbit model, we investigated the relationship between neural factors and steroid-induced osteonecrosis of the femoral head.
METHODS: Japanese white rabbits weighing about 3.5 kg each were injected with a single intramuscular dose of methylprednisolone 4 mg/kg and then divided into three groups (groups A, B and C) consisting of 15 rabbits each. The rabbits of group A were killed after 3 days, those of group B after 1 week, and those of group C after 2 weeks. As a control group, 10 rabbits (group N) were fed under the same conditions but did not receive a steroid injection. An immunohistochemical study of the femoral heads was conducted using the monoclonal antibodies CGRP, SP, VIP, NPY and NGF. Also, using the software Image Pro Plus, the areas showing positive immunoreactivity in each group were calculated and the four groups were compared.
RESULTS: significant changes were seen in the expression of CGRP, SP, VIP and NPY nerve fibres and of NGF immunoreactivity in the subchondral bone of the femoral head and these changes were associated with the process of osteonecrosis. Furthermore, CGRP, SP, NPY and NGF (but not VIP) showed marked changes in expression 1 week after steroid administration, and this is the time when osteonecrosis is thought to occur in this model.
CONCLUSION: This study showed that osteonecrosis in rabbits is chronologically associated with changes in neural factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204605     DOI: 10.1007/s00198-009-1159-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  75 in total

Review 1.  Therapeutic approaches to bone diseases.

Authors:  G A Rodan; T J Martin
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

Review 3.  Hyperalgesia and allodynia: peripheral mechanisms.

Authors:  Anne Coutaux; Frédéric Adam; Jean-Claude Willer; Daniel Le Bars
Journal:  Joint Bone Spine       Date:  2005-10       Impact factor: 4.929

4.  Bone reinnervation after fracture: a study in the rat.

Authors:  J Li; T Ahmad; M Spetea; M Ahmed; A Kreicbergs
Journal:  J Bone Miner Res       Date:  2001-08       Impact factor: 6.741

5.  Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat.

Authors:  E L Hill; R Elde
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

6.  Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development.

Authors:  J Cornish; K E Callon; U Bava; S A Kamona; G J Cooper; I R Reid
Journal:  Bone       Date:  2001-08       Impact factor: 4.398

7.  New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor.

Authors:  N Q McDonald; R Lapatto; J Murray-Rust; J Gunning; A Wlodawer; T L Blundell
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

Review 8.  Role of the endothelial cell in osteoclast control: new perspectives.

Authors:  M Zaidi; A S Alam; B E Bax; V S Shankar; C M Bax; J S Gill; M Pazianas; C L Huang; T Sahinoglu; B S Moonga
Journal:  Bone       Date:  1993 Mar-Apr       Impact factor: 4.398

9.  Nerve growth factor beta(NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth.

Authors:  A Letic-Gavrilovic; A Piattelli; K Abe
Journal:  J Mater Sci Mater Med       Date:  2003-02       Impact factor: 3.896

10.  Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs.

Authors:  Wolf Drescher; Karen P Weigert; Mathias H Bünger; Jørgen Ingerslev; Cody Bünger; Ebbe S Hansen
Journal:  J Orthop Res       Date:  2004-05       Impact factor: 3.494

View more
  4 in total

1.  Abnormal subchondral bone microstructure following steroid administration is involved in the early pathogenesis of steroid-induced osteonecrosis.

Authors:  L Wang; L Zhang; H Pan; S Peng; X Zhao; W W Lu
Journal:  Osteoporos Int       Date:  2015-07-09       Impact factor: 4.507

Review 2.  Experimental animal models of osteonecrosis.

Authors:  Meng Fan; Jiang Peng; Ling Qin; Shibi Lu
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 2.631

3.  Metabolic Disorders and Mineral Density of the Bone Tissue in the Early Pathogenesis of Osteonecrosis: Study on Rabbits with Steroid-Induced Osteonecrosis.

Authors:  L Wang; L Zhang; M Gao
Journal:  Bull Exp Biol Med       Date:  2021-04-24       Impact factor: 0.804

4.  Relation between the development of osteoporosis and osteonecrosis following glucocorticoid in a rabbit model.

Authors:  Tao Lin; Junbin Liu; Shuhua Yang; Xianzhe Liu; Xiaobo Feng; Dehao Fu
Journal:  Indian J Orthop       Date:  2016 Jul-Aug       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.